11/03/2026
Subcutaneous = self-injectable, right? Not necessarily.
One of the challenges with injectable medications is that the route of administration doesn’t tell the whole story.
Some SubQ (subcutaneous/below the skin) medications are designed for patients to administer themselves. Others must be administered by a healthcare professional. IM (intramuscular/into the muscle) medications can similarly vary between home and healthcare settings. IV (intravenous/into the vein) medications require professional administration, but even then, the appropriate setting can vary. Some therapies may also use different routes during different stages of treatment.
And these differences go beyond where someone receives a medication.
How the medication is obtained and administered can also affect how it appears in claims. Medications dispensed directly to a member commonly appear under the pharmacy benefit using an NDC, while provider-purchased and administered medications may appear under the medical benefit using a J- or Q-code.
The route is one piece of the puzzle. The complete medication pathway is what matters.
Understanding who administers a medication, where it can be administered, and how it is obtained provides a much clearer picture.